Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Brunner

Showing results (61-70 of 101) with videos related to

Pageof 11
Sort By:
Molecular Cancer|February 20, 2024
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcomeFelix Broghammer, Irina Korovina, Mahesh Gouda, et al.
Plos One|February 8, 2011
Protein kinase D2 is an essential regulator of murine myoblast differentiationAlexander Kleger, Christiane Loebnitz, Ganesh V Pusapati, et al.
Frontiers in Cell and Developmental Biology|September 8, 2022
Comparison of plasma- and saliva-derived exosomal miRNA profiles reveals diagnostic potential in head and neck cancerLinda Hofmann, Tsima Abou Kors, Jasmin Ezić, et al.
Cancers|August 6, 2020
Circulating Exosomes Inhibit B Cell Proliferation and ActivityJan C Schroeder, Lisa Puntigam, Linda Hofmann, et al.
International Journal of Molecular Sciences|July 26, 2020
Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and ImmunotherapyLisa K Puntigam, Sandra S Jeske, Marlies Götz, et al.
Neoplasia (New York, N.Y.)|November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cellsAdrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
International Journal of Molecular Sciences|December 23, 2022
Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment DecisionsAdrian von Witzleben, Urs Müller-Richter, Katja Maurus, et al.
Briefings in Bioinformatics|September 21, 2020
Analysis, identification and visualization of subgroups in genomicsGunnar Völkel, Simon Laban, Axel Fürstberger, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human diseaseFranziska Oliveri, Linda Neher, Ronja Pscheid, et al.
International Journal of Molecular Sciences|June 2, 2021
The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and InvasionLisa Schneider, Junnan Liu, Cheng Zhang, et al.
Pageof 11

Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Molecular Cancer|February 20, 2024
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcomeFelix Broghammer, Irina Korovina, Mahesh Gouda, et al.
Plos One|February 8, 2011
Protein kinase D2 is an essential regulator of murine myoblast differentiationAlexander Kleger, Christiane Loebnitz, Ganesh V Pusapati, et al.
Frontiers in Cell and Developmental Biology|September 8, 2022
Comparison of plasma- and saliva-derived exosomal miRNA profiles reveals diagnostic potential in head and neck cancerLinda Hofmann, Tsima Abou Kors, Jasmin Ezić, et al.
Cancers|August 6, 2020
Circulating Exosomes Inhibit B Cell Proliferation and ActivityJan C Schroeder, Lisa Puntigam, Linda Hofmann, et al.
International Journal of Molecular Sciences|July 26, 2020
Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and ImmunotherapyLisa K Puntigam, Sandra S Jeske, Marlies Götz, et al.
Neoplasia (New York, N.Y.)|November 28, 2024
5-Aza-2'-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cellsAdrian Fehn, Adrian von Witzleben, Ayla Grages, et al.
International Journal of Molecular Sciences|December 23, 2022
Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment DecisionsAdrian von Witzleben, Urs Müller-Richter, Katja Maurus, et al.
Briefings in Bioinformatics|September 21, 2020
Analysis, identification and visualization of subgroups in genomicsGunnar Völkel, Simon Laban, Axel Fürstberger, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Characterization of the adaptive immune response in a mouse model for HPV-positive head and neck squamous cell carcinoma with implications to human diseaseFranziska Oliveri, Linda Neher, Ronja Pscheid, et al.
International Journal of Molecular Sciences|June 2, 2021
The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and InvasionLisa Schneider, Junnan Liu, Cheng Zhang, et al.
Pageof 11